# Laclarée Vision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/laclaree-vision

- Industry: Medical Devices & Equipment
- Headquarters: Villeurbanne, France
- Website: www.laclaree-vision.com/
- Total disclosed funding: $4.5M
- Latest round: Seed (Jan 31, 2025)
- Investors on record: 3

## About

Based in France, Laclarée Vision focuses on developing innovative eyewear solutions that correct presbyopia, enhancing clarity and comfort for users in various settings.Laclarée Vision, founded in 2016 and headquartered in Villeurbanne, France, specializes in eyewear technology tailored for presbyopia correction. The company has engaged in four deals, with its latest funding round being a Grant of EUR 2.5 mn from EIC Accelerator on January 31, 2025. To date, Laclarée has raised a total of EUR 3.5 mn. Bruno Berge serves as the CEO, steering the company towards innovative product development.Laclarée specializes in the development of innovative eyewear designed specifically for the correction of presbyopia. Their core product offering is a variable-focus eyeglass solution that automatically adjusts to provide clear vision across all distances, effectively addressing the limitations associated with traditional multifocal lenses. These eyeglasses feature proprietary technology that combines aesthetic appeal with functionality for presbyopic users. Targeting a diverse customer base, Laclarée aims to enhance the daily visual experience of individuals experiencing age-related vision changes, primarily marketing in urban centers across Europe.Laclarée generates revenue primarily through direct-to-consumer sales of its variable-focus eyeglasses. Sales occur via direct purchases from the company’s website and partnerships with optical retailers. The pricing structure reflects their unique technology and the value provided to consumers. The company reported an EBITDA of EUR -190,223.3 for the most recent year, 2023, highlighting its current financial standing amidst its growth efforts.In January 2025, Laclarée Vision raised EUR 3.5 mn in Seed funding from Rimonci Capital, with participation from returning investors Kreaxi and High-Tech Gründerfonds. This funding will be utilized to create its first product for sale by mid-2026. The company aims to expand into new markets, with specific focus on regions where presbyopia is prevalent, enhancing its reach to a wider customer base.

## Funding rounds

- Seed, Jan 31, 2025, $3.6M — Kreaxi, High-Tech Gruenderfonds, Rimonci Capital
- Seed, May 6, 2020, $0.9M — Kreaxi, High-Tech Gruenderfonds

## Investors

- Kreaxi (https://capitalatlas.ai/funds/kreaxi) — Seed
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- Rimonci Capital (https://capitalatlas.ai/funds/rimonci-capital) — Seed